Contraception Research and Development

Recent papers from Contraception Research and Development

1. Proof-of-Concept Development and Preclinical Evaluation of a Microarray Patch Platform for Codelivery of Multiple Broadly Neutralizing Antibodies for HIV PreventionMolecular Pharmaceutics · 2026
2. Quantification of Antiretroviral Drug Emtricitabine in Human Plasma by Surface Enhanced Raman SpectroscopyACS Omega · 2024
3. Detection and quantification of antiviral drug tenofovir using silver nanoparticles and surface enhanced Raman spectroscopy (SERS) with spatially resolved hotspot selectionFrontiers in Nanotechnology · 2023
4. Mothers’ perceptions of their children’s weight: opportunity for health promotion in KuwaitEastern Mediterranean Health Journal · 2022
5. Cervical and systemic innate immunity predictors of HIV risk linked to genital herpes acquisition and time from HSV-2 seroconversionSexually Transmitted Infections · 2022
6. End-User Research in Support of Long-Acting Systemic Antiretroviral Delivery Systems: Insights from Qualitative Research with Providers and Target Users in South Africa2022
7. HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP UseJAIDS Journal of Acquired Immune Deficiency Syndromes · 2021
8. An Open-Label Pharmacokinetic and Pharmacodynamic Assessment of Tenofovir Gel and Oral Emtricitabine/Tenofovir Disoproxil FumarateAIDS Research and Human Retroviruses · 2021
9. Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in MiceViruses · 2021
10. Vitamin D Status Impacts Genital Mucosal Immunity and Markers of HIV-1 Susceptibility in WomenNutrients · 2020
11. The Role of Volume in the Perceptibility of Topical Vaginal Formulations: User Sensory Perceptions and Experiences of Heterosexual Couples During Vaginal SexAIDS Research and Human Retroviruses · 2020
12. Concomitant Imbalances of Systemic and Mucosal Immunity Increase HIV Acquisition RiskJAIDS Journal of Acquired Immune Deficiency Syndromes · 2020
13. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive ageSHILAP Revista de lepidopterología · 2020
14. Efficacy is Not Everything: Eliciting Women’s Preferences for a Vaginal HIV Prevention Product Using a Discrete-Choice ExperimentAIDS and Behavior · 2019
15. Extracellular Vesicles As Nanomedicine: Hopes And Hurdles In Clinical TranslationInternational Journal of Nanomedicine · 2019
16. Topical Inserts: A Versatile Delivery Form for HIV PreventionPharmaceutics · 2019
17. Perspectives from Young South African and Zimbabwean Women on Attributes of Four (Placebo) Vaginal Microbicide Delivery FormsAIDS and Behavior · 2019
18. Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal ringsPLoS ONE · 2019
19. End‐user preference for and choice of four vaginally deliveredHIVprevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover StudyJournal of the International AIDS Society · 2019
20. Development of a Transdermal Delivery System for Tenofovir Alafenamide, a Prodrug of Tenofovir with Potent Antiviral Activity Against HIV and HBVPharmaceutics · 2019